Patient-centered Outcomes During Using Self-ligating Brackets With or Without Piezocision vs Traditional Brackets

June 10, 2022 updated by: Damascus University

Evaluation of Patient-centered Outcomes Associated With Acceleration of Lower Incisors Decrowding Using Self-ligating Brackets With and Without Piezocision in Comparison With Traditional Brackets: A Randomized Controlled Clinical Trial

The different types of brackets (e.g., self-ligating and conventional brackets), and the various acceleration methods (e.g., corticotomy) cause varying degrees of pain and discomfort. This study will assess pain, discomfort, and other patient-centered outcomes in adults with severe crowding on the upper jaw requiring two first premolars extraction.

There are three groups:

The first group (control group): the patients in this group will be treated using conventional brackets alone.

The second group (Experimental group): the patients in this group will be treated using self-ligating brackets alone.

The third group (Experimental group): the patients in this group will be treated using self-ligating brackets associated with flapless corticotomy.

Study Overview

Detailed Description

Pain associated with orthodontic treatment is one of the undesirable complications, which negatively affects the patient's cooperation. Pain may occur due to the pressure on the periodontal ligaments induced by orthodontic forces. The perception of pain is affected by many factors related to the patient, such as age, gender and any previous treatment experiences, which are negatively or positively reflected on the patient's cooperation. As for the factors related to the type of orthodontic treatment provided, the pain and discomfort are proportional to the brackets system used and the forces applied, especially in the leveling and alignment stage. The amount of tooth movement is directly affected by the friction between the brackets and the wires used. The physical properties of the wire and brackets used and the dimensions of the applied wires, in addition to the type of ligation play a significant role in the amount of friction generated.

Study Type

Interventional

Enrollment (Actual)

63

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 28 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. The patient's age is between 18 and 25 years
  2. Severe crowding on the upper jaw (more than 6 mm) requires upper first premolars extraction
  3. Little's Index of Irregularity is greater than 7 mm
  4. Overbite ranging between 0-4 mm
  5. Normal inclination of the upper incisors
  6. No missing teeth (except for third molars)
  7. Class I or class II (ANB ≤ 5) or class III (ANB ≥ 0)

Exclusion Criteria:

  1. The presence of any systemic disease affecting orthodontic movement
  2. The presence of congenital syndromes or cleft lip and palate
  3. Poor oral health with a plaque index greater than (1)
  4. Skeletal maxillary constriction

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Fixed appliance
Patients in this group will be treated using traditional brackets alone.
MBT 0.022 perception traditional braces will be used without any acceleration method.
EXPERIMENTAL: Self-ligaton appliance
Patients in this group will be treated using self-ligating brackets alone.
MBT 0.022 perception Self-ligating braces will be used without any acceleration method.
EXPERIMENTAL: Self-ligaton appliance + piezocision
Patients in this group will be treated using self-ligating brackets associated with piezocision.
Flapless corticotomy will be applied for the upper anterior teeth.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in the levels of pain
Time Frame: After 24 hours; 4 days; 7 days; 14 days; 28 days

Patients will be asked this question about their feeling of pain (Item no 01):

'What is the degree of pain you have experienced?' A standardized questionnaire will be used to assess pain, discomfort and functional impairments' levels during the active phase of treatment. The patient will be asked to specify a point on the visual analogue scale (VAS), a 100-mm horizontal line with two focal points at its beginning and end (0: there is no pain - 100: the worst pain). The score will be determined by measuring the distance from the beginning until the point identified by the patient.

After 24 hours; 4 days; 7 days; 14 days; 28 days
Change in the levels of discomfort
Time Frame: After 24 hours; 4 days; 7 days; 14 days; 28 days

Patients will be asked this question about their feeling of discomfort (Item no 02):

'What is the degree of discomfort you have experienced?' A standardized questionnaire will be used to assess pain, discomfort and functional impairments' levels during the active phase of treatment. The patient will be asked to specify a point on the visual analogue scale (VAS), a 100-mm horizontal line with two focal points at its beginning and end (0: there is no pain - 100: the worst pain). The score will be determined by measuring the distance from the beginning until the point identified by the patient.

After 24 hours; 4 days; 7 days; 14 days; 28 days
Change in the Perception of swelling
Time Frame: After 24 hours; 4 days; 7 days; 14 days; 28 days

Patients will be asked this question about their feeling of swelling (Item no 03):

'What is the degree of swelling you have experienced?' A standardized questionnaire will be used to assess pain, discomfort and functional impairments' levels during the active phase of treatment. The patient will be asked to specify a point on the visual analogue scale (VAS), a 100-mm horizontal line with two focal points at its beginning and end (0: there is no pain - 100: the worst pain). The score will be determined by measuring the distance from the beginning until the point identified by the patient.

After 24 hours; 4 days; 7 days; 14 days; 28 days
Change in the difficulty of mastication
Time Frame: After 24 hours; 4 days; 7 days; 14 days; 28 days
'What is the degree of mastication difficulties you have experienced?' A standardized questionnaire will be used to assess pain, discomfort and functional impairments' levels during the active phase of treatment. The patient will be asked to specify a point on the visual analogue scale (VAS), a 100-mm horizontal line with two focal points at its beginning and end (0: there is no pain - 100: the worst pain). The score will be determined by measuring the distance from the beginning until the point identified by the patient.
After 24 hours; 4 days; 7 days; 14 days; 28 days
Change in the difficulty of swallowing
Time Frame: After 24 hours; 4 days; 7 days; 14 days; 28 days

Patients will be asked this question about their feeling of swallowing (Item no 05):

'What is the degree of swallowing difficulties you have experienced?' A standardized questionnaire will be used to assess pain, discomfort and functional impairments' levels during the active phase of treatment. The patient will be asked to specify a point on the visual analogue scale (VAS), a 100-mm horizontal line with two focal points at its beginning and end (0: there is no pain - 100: the worst pain). The score will be determined by measuring the distance from the beginning until the point identified by the patient.

After 24 hours; 4 days; 7 days; 14 days; 28 days
Change in the perception of the jaw movement restriction
Time Frame: After 24 hours; 4 days; 7 days; 14 days; 28 days

Patients will be asked this question about their feeling of the jaw movement restriction (Item no 06):

'What is the degree of the jaw movement restriction you have experienced?' A standardized questionnaire will be used to assess pain, discomfort and functional impairments' levels during the active phase of treatment. The patient will be asked to specify a point on the visual analogue scale (VAS), a 100-mm horizontal line with two focal points at its beginning and end (0: there is no pain - 100: the worst pain). The score will be determined by measuring the distance from the beginning until the point identified by the patient.

After 24 hours; 4 days; 7 days; 14 days; 28 days
The levels of satisfaction
Time Frame: This outcome will be assessed at 28 days following the beginning of treatment
Patients will be asked this question about their levels of satisfaction (Item no 07): 'What is your levels of satisfaction on the orthodontic treatment provided?' A standardized questionnaire will be used to assess pain, discomfort and functional impairments' levels during the active phase of treatment. The patient will be asked to specify a point on the visual analogue scale (VAS), a 100-mm horizontal line with two focal points at its beginning and end (0: there is no satisfaction- 100: the highest satisfaction). The score will be determined by measuring the distance from the beginning until the point identified by the patient.
This outcome will be assessed at 28 days following the beginning of treatment
Recommendation of the procedure to a friend
Time Frame: This outcome will be assessed at 28 days following the beginning of treatment
Patients will be asked this question (Item no 08): 'Would you recommend a friend undergo this treatment?' Assessment will be performed using a two-point scale to answer yes or no.
This outcome will be assessed at 28 days following the beginning of treatment
The possibility of repeating the procedure
Time Frame: This outcome will be assessed at 28 days following the beginning of treatment
Patients will be asked this question about the possibility of repeating the procedure (Item no 09): 'Would you accept to undergo this treatment again?' Assessment will be performed using a two-point scale to answer yes or no.
This outcome will be assessed at 28 days following the beginning of treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Heba M Al-Ibrahim, DDS,MSc, Department of orthodontics, Damascus University, Syria
  • Study Director: Mohammad Y Hajeer, DDS,MSc,PhD, Professor of Orthodontics, University of Damascus Dental School, Damascus, Syria.
  • Study Director: Issam ِAlkhoury, DDS,MSc,PhD, Professor of Oral and Maxillofacial Surgery, University of Damascus Dental School, Damascus, SYRIA

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

April 14, 2019

Primary Completion (ACTUAL)

October 7, 2020

Study Completion (ACTUAL)

August 22, 2021

Study Registration Dates

First Submitted

June 5, 2022

First Submitted That Met QC Criteria

June 8, 2022

First Posted (ACTUAL)

June 13, 2022

Study Record Updates

Last Update Posted (ACTUAL)

June 14, 2022

Last Update Submitted That Met QC Criteria

June 10, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • UDDS-Ortho-11-2022

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Crowding, Tooth

Clinical Trials on Traditional braces

3
Subscribe